Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TBPHTBPH
Showing 8 of 30 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in THERAVANCE BIOPHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.1M shares of TBPH (THERAVANCE BIOPHARMA INC), worth $18.5M as of 2026-Q1. The position was increased (+21.2% shares). TBPH represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$18.5M

Current Shares

1.1M

Total Value Change

+$11.2M

Total Shares Change

+280,076

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.1M
+21.2%
$18.5M0.0%$13.96
34
2025-Q4
Increased
938,724
+4.5%
$17.6M0.0%$18.91
30
2025-Q3
Increased
897,990
+0.5%
$13.1M0.0%$14.43
28
2025-Q2
Increased
893,983
+0.4%
$9.9M0.0%$11.22
28
2025-Q1
Increased
890,567
+3.2%
$8M0.0%$9.23
28
2024-Q4
Increased
862,802
+0.6%
$8.1M0.0%$9.47
28
2024-Q3
Increased
857,979
+0.1%
$6.9M0.0%$8.10
27
2024-Q2
Decreased
857,386
-11.4%
$7.3M0.0%$8.48
0

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used